TheJournal.ie
HSE to fund Friedreich's Ataxia drug after improved price but notes 'limited efficacy'
The HSE said it ‘took account of a substantially improved financial offer made in recent days by the company Biogen’.
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.